glp-1 weight loss type 1 diabetes Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Medications – Community Education

Retatrutide is a groundbreaking triple agonist currently in Phase 3 trials that is redefining what is possible without surgery: Triple-Action Mechanism: Unlike Wegovy (1 receptor) or Zepbound (2 receptors), Retatrutide targets three hormones: GLP-1, GIP, and Glucagon

The trial included a non-alcoholic fatty liver disease (NAFLD) cohort, where the drug helped patients reduce liver fat and improve insulin sensitivity

This is significant, considering that data from Blue Cross Blue Shield found that over 63% of GLP-1 patients from 2014 to 2023 were in this age group

What does research-only mean

All retatrutide 10mg peptide products are shipped with cold packs and heat tracking to keep best conditions during transit

As these peoples dietary habits shift, it leads to a decline in caloric intake and an increased focus on portion control